ASGE members benefit from an array of publications and newsletters in various formats to keep abreast of latest developments in GI endoscopy.

Gastrointestinal Endoscopy (GIE) is ASGE’s preeminent internationally recognized journal on the science and practice of endoscopy   

VideoGIE, an online-only, open access video journal featuring peer-reviewed video case reports and case series of endoscopic procedures

iGIE, the latest ASGE publication; a gold open-access, online only journal that accelerates the publication of peer-reviewed research and best practices, including the work conducted collaboratively and across disciplines

Journal Scan, a weekly newsletter providing expert insights into the latest GI research, offered in two versions:

SCOPE provides a weekly news round-up on all things going on with ASGE and its members around the world

Daily Digest is a succinct quick-read for busy members looking for brief snippets of all that’s going on

Practical Solutions is a monthly newsletter offering resources for the GI team

Trainee Advisor provides a quarterly round-up of news and activities for fellows along their GI pathway

Additional publications that ASGE offers include:


Patient Brochures

Most Recent Practice Guidelines

SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease

Nov 14, 2016, 20:27 PM
Patients with ulcerative colitis or Crohn’s colitis have an increased risk of colorectal cancer (CRC). Most cases are believed to arise from dysplasia, and surveillance colonoscopy therefore is recommended to detect dysplasia. Detection of dysplasia traditionally has relied on both examination of the mucosa with targeted biopsies of visible lesions and extensive random biopsies to identify invisible dysplasia. Current U.S. guidelines recommend obtaining at least 32 random biopsy specimens from all segments of the colon as the foundation of endoscopic surveillance.1-4 However, much of the evidence that provides a basis for these recommendations is from older literature, when most dysplasia was diagnosed on random biopsies of colon mucosa.5 With the advent of video endoscopy and newer endoscopic technologies, investigators now report that most dysplasia discovered in patients with inflammatory bowel disease (IBD) is visible.6,7 Such a paradigm shift may have important implications for the surveillance and management of dysplasia.
Title : SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease
Doi org link :
Volume : Gastrointest Endosc 2015;81:489–501.e26
URL : /docs/default-source/importfiles/publications_(public)/practice_guidelines/scenic_consensus_statement.pdf?Status=Master&sfvrsn=2
Select a choice : Keep
Content created : Oct 15, 2014, 04:05 AM
File size :
Number :
ExternalPK : 17594
Categories :
  • Endoscopy in Inflammatory Bowel Disease
  • Gastrointestinal Endoscopy Journal
  • Practice Guidelines
Tags :